Cargando…
Pharmacokinetics of Pantoprazole and Pantoprazole Sulfone in Goats After Intravenous Administration: A Preliminary Report
Background: Ruminant species are at risk of developing abomasal ulceration, but there is a lack of pharmacokinetic data for anti-ulcer therapies, such as the proton pump inhibitor pantoprazole, in goats. Objective: The primary study objective was to estimate the plasma pharmacokinetic parameters for...
Autores principales: | Smith, Joe S., Mochel, Jonathan P., Soto-Gonzalez, Windy M., Rahn, Rebecca R., Fayne, Bryanna N., Escher, Olivia G., Geletka, Anastasia M., Harvill, Lainey E., Bergman, Joan B., Cox, Sherry |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8492921/ https://www.ncbi.nlm.nih.gov/pubmed/34631865 http://dx.doi.org/10.3389/fvets.2021.744813 |
Ejemplares similares
-
Pharmacokinetic and pharmacodynamic properties of pantoprazole in calves
por: Olivarez, Jeff D., et al.
Publicado: (2023) -
Pharmacokinetics of esomeprazole in goats (Capra aegagrus hircus) after intravenous and subcutaneous administration
por: Fladung, Rachel, et al.
Publicado: (2022) -
Pharmacokinetics and Tissue Levels of Pantoprazole in Neonatal Calves After Intravenous Administration
por: Olivarez, Jeff D., et al.
Publicado: (2020) -
A Retrospective Clinical Investigation of the Safety and Adverse Effects of Pantoprazole in Hospitalized Ruminants
por: Smith, Joseph S., et al.
Publicado: (2020) -
The pharmacokinetics and pharmacodynamics of esomeprazole in sheep after intravenous dosing
por: Smith, Joe S., et al.
Publicado: (2023)